Viewing Study NCT01224366


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-28 @ 1:20 PM
Study NCT ID: NCT01224366
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2010-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module